期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Conservation Strategy for African Medicinal Species: In Vitro Biotechnological Approach 被引量:1
1
作者 Priyanka Jha Swati Chahal +3 位作者 devendra kumar pandey Joginder Singh Ram Prasad Vijay kumar 《Phyton-International Journal of Experimental Botany》 SCIE 2020年第4期779-794,共16页
The use of medicinal plants for different therapeutic values is well documented in African continent.African diverse biodiversity hotspots provide a wide range of endemic species,which ensures a potential medicinal va... The use of medicinal plants for different therapeutic values is well documented in African continent.African diverse biodiversity hotspots provide a wide range of endemic species,which ensures a potential medicinal value.The feasible conservation approach and sustainable harvesting for the medicinal species remains a huge challenge.However,conservation approach through different biotechnological tools such as micropropagation,somatic embryogenesis,synthetic seed production,hairy root culture,molecular markers based study and cryopreservation of endemic African medicinal species is much crucial.In this review,an attempt has been made to provide different in vitro biotechnological approaches for the conservation of African medicinal species.The present review will be helpful in further technology development and deciding the priorities at decision-making levels for in vitro conservation and sustainable use of African medicinal species. 展开更多
关键词 Biotechnological approach conservation medicinal plant African traditional medicine(ATM) start codon targeted polymorphism(SCoT) somatic embryogenesis
在线阅读 下载PDF
Cancer chemotherapy and beyond:Current status,drug candidates,associated risks and progress in targeted therapeutics 被引量:19
2
作者 Uttpal Anand Abhijit Dey +11 位作者 Arvind K.Singh Chandel Rupa Sanyal Amarnath Mishra devendra kumar pandey Valentina De Falco Arun Upadhyay Ramesh Kandimalla Anupama Chaudhary Jaspreet Kaur Dhanjal Saikat Dewanjee Jayalakshmi Vallamkondu José M.Pérez de la Lastra 《Genes & Diseases》 SCIE CSCD 2023年第4期1367-1401,共35页
Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and produce aggressive malignancies that causes millions of deaths every year.With the new understanding of the molecular mechanism(s)... Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and produce aggressive malignancies that causes millions of deaths every year.With the new understanding of the molecular mechanism(s)of disease progression,our knowledge about the disease is snowballing,leading to the evolution of many new therapeutic regimes and their successive trials.In the past few decades,various combinations of therapies have been pro-posed and are presently employed in the treatment of diverse cancers.Targeted drug therapy,immunotherapy,and personalized medicines are now largely being employed,which were not common a few years back.The field of cancer discoveries and therapeutics are evolving fast as cancer type-specific biomarkers are progressively being identified and several types of cancers are nowadays undergoing systematic therapies,extending patients’disease-free survival thereafter.Although growing evidence shows that a systematic and targeted approach could be the future of cancer medicine,chemotherapy remains a largely opted therapeutic option despite its known side effects on the patient’s physical and psychological health.Chemother-apeutic agents/pharmaceuticals served a great purpose over the past few decades and have remained the frontline choice for advanced-stage malignancies where surgery and/or radiation therapy cannot be prescribed due to specific reasons.The present report succinctly reviews the existing and contemporary advancements in chemotherapy and assesses the status of the enrolled drugs/pharmaceuticals;it also comprehensively discusses the emerging role of specific/targeted therapeutic strategies that are presently being employed to achieve better clinical success/survival rate in cancer patients. 展开更多
关键词 Antimicrobial peptides Cancer therapies Clinical trials Combination therapy IMMUNOTHERAPY Patient survival Personalized medicine Targeted drug delivery
原文传递
Corrigendum to'Cancer chemotherapy and beyond:Current status,drug candidates,associated risks and progress in targeted therapeutics'[Genes&Diseases 10(2023)1367-1401] 被引量:2
3
作者 Uttpal Anand Abhijit Dey +11 位作者 Arvind K.Singh Chandel Rupa Sanyal Amarnath Mishra devendra kumar pandey Valentina De Falco Arun Upadhyay Ramesh Kandimalla Anupama Chaudhary Jaspreet Kaur Dhanjal Saikat Dewanjee Jayalakshmi Vallamkondu Jose M.Perez de la Lastra 《Genes & Diseases》 SCIE CSCD 2024年第4期426-427,共2页
In the published article,there was an error in the affiliation information about the first author Uttpal Anand[a].Instead of"Department of Life Sciences,Ben-Gurion University of the Negev,Beer-Sheva 84105,Israel&... In the published article,there was an error in the affiliation information about the first author Uttpal Anand[a].Instead of"Department of Life Sciences,Ben-Gurion University of the Negev,Beer-Sheva 84105,Israel",it should be"CytoGene Research&Development LLP,K-51,UPSIDA Industrial Area,Kursi Road(Lucknow),Dist.Barabanki,225001,Uttar Pradesh,India".The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of thearticle inanyway. 展开更多
关键词 Cancer COR TARGETED
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部